A study of retinal penetration of intravitreal tenecteplase in pigs

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 6, 2006, Pages 2662-2667

  Kwan, Anthony S L ^a   Vijayasekaran, Sarojini ^a   McAllister, Ian L ^a   Yu, Paula K ^a   Yu, Dao Yi ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TENECTEPLASE; FIBRINOLYTIC AGENT; FLUORESCENT DYE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; DRUG PENETRATION; EPIFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RETINA; STATISTICAL ANALYSIS; SWINE; VITREOUS BODY; ACTIVE TRANSPORT; ANIMAL; ANIMAL MODEL; BLOOD RETINA BARRIER; FLUORESCENCE MICROSCOPY; INJECTION; METABOLISM; PHYSIOLOGY; RETINA HEMORRHAGE;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-RETINAL BARRIER; FIBRINOLYTIC AGENTS; FLUORESCENT DYES; INJECTIONS; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; RETINA; RETINAL HEMORRHAGE; SWINE; TISSUE PLASMINOGEN ACTIVATOR; VITREOUS BODY;

EID: 33745674975     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1019     Document Type: Article

References (41)

1. Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol. 1997;42:195-213.
2. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol. 1990;109:33-37.
3. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16:183-189.
4. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol. 1996;122:486-493.
5. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213:97-102.
6. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900-1906.
7. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. Ophthalmology. 2004;111:1201-1208.
8. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol. 1998;116:1326-1332.
9. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996;121:267-275.
10. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol. 1994;118:559-568.
11. Vander JF. Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy. Ophthalmic Surg. 1992;23:361-363.
12. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. 1988;105:25-29.
13. Hanscom TA, Diddie KR. Early surgical drainage of macular subretinal hemorrhage. Arch Ophthalmol. 1987;105:1722-1723.
14. Collen D, Lijnen HR. Tissue-type plasminogen activator: mechanisms of action and thrombolytic properties. Haemostasis. 1986;16(suppl 3):25-32.
15. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. 1999;128:739-746.
16. Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol. 1991;109:718-722.
17. Benner JD, Morse LS, Toth CA, Landers MB III, Hjelmeland LM. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol. 1991;109:1731-1736.
18. Hrach CJ, Johnson MW, Hassan AS, Lei B, Sieving PA, Elner VM. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol. 2000;118:659-663.
19. Chen SN, Yang TC, Ho CL, Kuo YH, Yip Y, Chao AN. Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology. 2003;110:704-708.
20. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. 1999;237:273-277.
21. Davydov L, Cheng JW. Tenecteplase: a review. Clin Ther. 2001;23:982-997.
22. Nordt TK, Bode C. Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Heart. 2003;89:1358-1362.
23. ASSENT-2 Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet. 1999;354:716-722.
24. Sinnaeve P, Alexander J, Belmans A, et al. One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction. Am Heart J. 2003;146:27-32.
25. Van de WF, Cannon CP, Luyten A, et al. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. Am Heart J. 1999;137:786-791.
26. Rowley SA, Vijayasekaran S, Yu PK, McAllister IL, Yu DY. Retinal toxicity of intravitreal tenecteplase in the rabbit. Br J Ophthalmol. 2004;88:573-578.
27. Johnson MW. Pneumatic displacement of submacular hemorrhage. Curr Opin Ophthalmol. 2000;11:201-206.
28. Boone DE, Boldt HC, Ross RD, Folk JC, Kimura AE. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina. 1996;16:518-524.
29. Smelser GK, Ishikawa T, Pei YF. Electron microscopic studies if intravitreal spaces diffusion of particulate materials. In: Rohen JW, ed. Structure of the Eye, II. Symposium. Sttuttgart, Germany: Schattauer-Verlaug; 1965;109-120.
30. Marmor MF, Negi A, Maurice DM. Kinetics of macromolecules injected into the subretinal space. Exp Eye Res. 1985;40:687-696.
31. Pitkanen L, Pelkonen J, Ruponen M, Ronkko S, Urtti A. Neural retina limits the non-viral gene transfer to retinal pigment epithelium in an in vitro bovine eye model. AAPS J. 2004;6:Article 25.
32. Hagerman GS, Johnson LV. Chondroitin-6-sulphate glycosoaminoglycan is a major constituent of primate cone photoreceptor matrix and sheaths. Curr Eye Res. 1987;6:639-646.
33. Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane. Invest Ophthalmol Vis Sci. 1991;32:1986-1995.
34. Heegaard S, Jensen OA, Prause JU. Structure and composition of the inner limiting membrane of the retina. Graefes Arch Clin Exp Ophthalmol. 1986;224:355-360.
35. Chai L, Morris JE. Distribution of heparin sulfate proteoglycan in embryonic chicken neural retina and isolated inner limiting membrane. Curr Eye Res. 1994;13:669-677.
36. Takeuchi A, Kricorian G, Yao XY, Kenny JW, Marmor MF. The rate and source of albumin entry into saline-filled experimental retinal detachments. Invest Ophthalmol Vis Sci. 1994;35:3792-3798.
37. Lu DW. The changes of vitreous pH values in an acute glaucoma rabbit model. J Ocul Pharmacol Ther. 2001;17:343-350.
38. Anderson MV. Changes in the vitreous body pH of pigs after retinal xenen photocoagulation. Acta Ophthalmol. 1999;69;2:193-199.
39. Prince JH, McConnell DG. Retina and optic nerve. In: Prince JH, ed. The Rabbit in Eye Research. Springfield, IL: CC Thomas; 1964:385-448.
40. Johnson MW, Olsen KR, Hernandez E, Irvine WD, Johnson RN. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol. 1990;108:259-263.
41. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol. 2001;119:28-32.